| 000 | 01890 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250518055531.0 | ||
| 264 | 0 | _c20200303 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1521-0111 | ||
| 024 | 7 |
_a10.1124/mol.119.116129 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCao, Zhi-Xing | |
| 245 | 0 | 0 |
_aIsoliquiritigenin, an Orally Available Natural FLT3 Inhibitor from Licorice, Exhibits Selective Anti-Acute Myeloid Leukemia Efficacy In Vitro and In Vivo. _h[electronic resource] |
| 260 |
_bMolecular pharmacology _c11 2019 |
||
| 300 |
_a589-599 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aChalcones _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlycyrrhiza |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred NOD |
| 650 | 0 | 4 | _aMice, SCID |
| 650 | 0 | 4 |
_aMolecular Docking Simulation _xmethods |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aXenograft Model Antitumor Assays _xmethods |
| 650 | 0 | 4 |
_afms-Like Tyrosine Kinase 3 _xantagonists & inhibitors |
| 700 | 1 | _aWen, Yi | |
| 700 | 1 | _aHe, Jun-Lin | |
| 700 | 1 | _aHuang, Shen-Zhen | |
| 700 | 1 | _aGao, Fei | |
| 700 | 1 | _aGuo, Chuan-Jie | |
| 700 | 1 | _aLiu, Qing-Qing | |
| 700 | 1 | _aZheng, Shu-Wen | |
| 700 | 1 | _aGong, Dao-Yin | |
| 700 | 1 | _aLi, Yu-Zhi | |
| 700 | 1 | _aZhang, Ruo-Qi | |
| 700 | 1 | _aChen, Jian-Ping | |
| 700 | 1 | _aPeng, Cheng | |
| 773 | 0 |
_tMolecular pharmacology _gvol. 96 _gno. 5 _gp. 589-599 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/mol.119.116129 _zAvailable from publisher's website |
| 999 |
_c30054447 _d30054447 |
||